Gene · 54880
Papers3,332
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 3,332
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrated analysis of human DNA methylation, gene expression, and genomic variation in iMETHYL database using kernel tensor decomposition-based unsupervised feature extraction. | PLoS One | 2023 | 37556429 | PubTator, text mining | PubMed |
| Primary mediastinum Ewing's sarcoma with pleural effusion: A case report and literature review. | Open Life Sci | 2023 | 37554964 | PubTator, text mining | PubMed |
| [Venetoclax combined with hypomethylating agents induced tumor lysis syndrome in patients with acute leukemia: 7 cases report and literature review]. | Zhonghua Xue Ye Xue Za Zhi | 2023 | 37550210 | PubTator, text mining | PubMed |
| [Molecular features of 109 patients with chronic myelomonocytic leukemia in a single center]. | Zhonghua Xue Ye Xue Za Zhi | 2023 | 37550186 | PubTator, text mining | PubMed |
| Clinical outcome of therapy-related acute myeloid leukemia patients. Real-life experience in a University Hospital and a Cancer Center in France. | Cancer Med | 2023 | 37548369 | PubTator, text mining | PubMed |
| Evaluation of new IPSS-Molecular model and comparison of different prognostic systems in patients with myelodysplastic syndrome. | Blood Sci | 2023 | 37546714 | PubTator, text mining | PubMed |
| TdT-positive high-grade B-cell lymphoma with BCOR and IDH1 mutations. | Pathology | 2023 | 37544875 | PubTator, text mining | PubMed |
| Targeting Bcl-xL is a potential therapeutic strategy for extranodal NK/T cell lymphoma. | iScience | 2023 | 37539026 | PubTator, text mining | PubMed |
| Efficacy and safety of avatrombopag in aplastic anemia patients with liver disease. | J Transl Int Med | 2023 | 37533842 | PubTator, text mining | PubMed |
| High-grade endometrial stromal sarcoma with YWHAE-NUTM2B fusion gene abnormality identified after 10 years of recurrent pulmonary metastases: A case report. | Gynecol Oncol Rep | 2023 | 37533428 | PubTator, text mining | PubMed |
| Genomic alterations of oligodendrogliomas at distant recurrence. | Cancer Med | 2023 | 37533228 | PubTator, text mining | PubMed |
| Primary pleomorphic liposarcoma of bone: A case report with literature review. | Int J Surg Case Rep | 2023 | 37531877 | PubTator, text mining | PubMed |
| Extranodal NK-/T-cell lymphoma, nasal type: what advances have been made in the last decade? | Front Oncol | 2023 | 37529691 | PubTator, text mining | PubMed |
| [Primary sarcoma with internal tandem duplication of BCOR in fibula: report of a case]. | Zhonghua Bing Li Xue Za Zhi | 2023 | 37527999 | PubTator, text mining | PubMed |
| The curious case of IDH mutant acute myeloid leukaemia: biochemistry and therapeutic approaches. | Biochem Soc Trans | 2023 | 37526143 | PubTator, text mining | PubMed |
| Prognostic impact of secondary versus de novo ontogeny in acute myeloid leukemia is accounted for by the European LeukemiaNet 2022 risk classification. | Leukemia | 2023 | 37524919 | PubTator, text mining | PubMed |
| A comprehensive genomic study of 390 H3F3A-mutant pediatric and adult diffuse high-grade gliomas, CNS WHO grade 4. | Acta Neuropathol | 2023 | 37524847 | PubTator, text mining | PubMed |
| The transcriptome of HTLV-1-infected primary cells following reactivation reveals changes to host gene expression central to the proviral life cycle. | PLoS Pathog | 2023 | 37523412 | PubTator, text mining | PubMed |
| A cystic non-Wilms renal tumor in a Nepalese boy: A rare case of clear cell sarcoma. | Int J Surg Case Rep | 2023 | 37517259 | PubTator, text mining | PubMed |
| HER2-Positive Gastric Cancer: The Role of Immunotherapy and Novel Therapeutic Strategies. | Int J Mol Sci | 2023 | 37511163 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54880/papers?page=24